These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India. Sudarshan MK, Narayana DH, Madhusudana SN, Holla R, Ashwin BY, Gangaboraiah B, Ravish HS. Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446 [Abstract] [Full Text] [Related]
5. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH, Madhusudana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HH, Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, Shamanna M. Vaccine; 2009 Dec 10; 28(1):148-51. PubMed ID: 19818720 [Abstract] [Full Text] [Related]
6. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. Ma J, Wang H, Li J, Chang L, Xie Y, Liu Z, Zhao Y, Malerczyk C. Hum Vaccin Immunother; 2014 Dec 10; 10(10):2805-12. PubMed ID: 25483635 [Abstract] [Full Text] [Related]
13. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. Wongsaroj P, Udomchaisakul P, Tepsumethanon S, Khawplod P, Tantawichien T. Vaccine; 2013 Mar 25; 31(13):1748-51. PubMed ID: 23370149 [Abstract] [Full Text] [Related]
14. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China. Li R, Huang L, Li J, Mo Z, He B, Wang Y, Wu X, Minutello M, Guinet-Morlot F, Pichon S. Vaccine; 2013 Dec 05; 31(50):5940-7. PubMed ID: 24148575 [Abstract] [Full Text] [Related]
15. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Vaccine; 2006 May 08; 24(19):4116-21. PubMed ID: 16545510 [Abstract] [Full Text] [Related]
16. Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis. Preiss S, Chanthavanich P, Chen LH, Marano C, Buchy P, van Hoorn R, Vonk Noordegraaf M, Mukherjee P. Expert Rev Vaccines; 2018 Jun 08; 17(6):525-545. PubMed ID: 29939085 [Abstract] [Full Text] [Related]
17. Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study. Sampath G, Banzhoff A, Deshpande A, Malerczyk C, Arora AK, Vakil H, Preiss S. Hum Vaccin Immunother; 2017 Jul 03; 13(7):1531-1538. PubMed ID: 28406752 [Abstract] [Full Text] [Related]
18. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines. Quiambao BP, Ambas C, Diego S, Bosch Castells V, Korejwo J, Petit C, Houillon G. Vaccine; 2019 Apr 10; 37(16):2268-2277. PubMed ID: 30890382 [Abstract] [Full Text] [Related]